Kiniksa Pharmaceuticals International, plc (KNSA) Insider Trading

Name: Kiniksa Pharmaceuticals International, plc (KNSA) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 3, 2026): Ragosa Mark (CHIEF FINANCIAL OFFICER): Exercise/Conversion of 2,694 shares.

Get alerted when insiders trade KNSA

Email address

Loading company data...

INSIDERSNOTIFIER

Email alerts for SEC Form 4 insider trading filings.

Product

Explore
Stats
Weekly roundup
Guides
FAQ
API(opens in a new tab)

Account

Manage alerts
Unsubscribe

Legal

Disclaimer
Contact

System status Powered by RapidAPI Insiders

Beta

INSIDERSNOTIFIER

Explore Stats FAQ

Manage alerts Get alerts

INSIDERSNOTIFIER

Loading company details...

INSIDERSNOTIFIER

Email alerts for SEC Form 4 insider trading filings.

Product

Explore
Stats
Weekly roundup
Guides
FAQ
API(opens in a new tab)

Account

Manage alerts
Unsubscribe

Legal

Disclaimer
Contact

System status Powered by RapidAPI Insiders

Beta

INSIDERSNOTIFIER

Explore Stats FAQ

Manage alerts Get alerts

INSIDERSNOTIFIER

Kiniksa Pharmaceuticals International, plc (KNSA) Insider Trading

Latest Form 4 (Sep 3, 2026): Ragosa Mark (CHIEF FINANCIAL OFFICER): Exercise/Conversion of 2,694 shares.

Get alerted when insiders trade KNSA

Email address

Loading company data...

INSIDERSNOTIFIER

Email alerts for SEC Form 4 insider trading filings.

Product

Explore
Stats
Weekly roundup
Guides
FAQ
API(opens in a new tab)

Account

Manage alerts
Unsubscribe

Legal

Disclaimer
Contact

System status Powered by RapidAPI Insiders

Beta